The Consistent Regulation of E-Cigarette Flavor in the Philippines

Apr.14.2025
The Consistent Regulation of E-Cigarette Flavor in the Philippines
Philippine Justice Secretary clarifies no conflict between RA 11467 and RA 11900 in e-cigarette flavor regulation.

Key points:

The Filipino Justice Secretary emphasized that RA 11467 and RA 11900 do not conflict in regulating e-cigarette flavors.

RA 11467 prohibits e-cigarette products with flavors other than tobacco and mint, while RA 11900 regulates the use of flavor descriptions. Both laws work together to enforce strict regulation of e-cigarette flavors.

Two pieces of legislation jointly regulate the sale and promotion of e-cigarette products.


According to Malaya Business Insight on April 14th, Filipino Justice Secretary Jesus Crispin Remulla stated that the ban on flavored e-cigarette products remains in effect under Republic Act 11467. Despite the implementation of the Vaporized Nicotine and Non-Nicotine Products Act (RA 11900), these two laws do not conflict when it comes to regulating e-cigarette flavors.

 

Remulla stated in a legal opinion publicly released on April 13 that Republic Act 11467 and RA 11900 are consistent in regulating the flavors of e-cigarette products.

 

Two years ago, former President Rodrigo Duterte signed RA 11467 into law, while RA 11900 automatically took effect two years later. Health Minister Teodoro Herbosa has therefore requested legal guidance to clarify the relationship between the two laws regarding the regulation of e-cigarette flavors.

 

Hebosa pointed out that RA 11467 prohibits the use of flavors other than original tobacco and mint, while RA 11900 regulates the use of flavor descriptors. Legal guidance is needed to clarify whether the flavor descriptor ban in RA 11900 conflicts with the flavor ban in another law. The opinion of the Department of Justice on this issue is crucial, as Section 29 of RA 11900 stipulates that any laws inconsistent with it will be repealed or amended.

 

Remulla emphasized that the purpose of the two laws is to regulate the sales and distribution of e-cigarette products, including those containing nicotine and those that do not. RA 11900 provides specific guidelines for the marketing of these products but does not repeal the provisions of RA 11467 regarding the ban on flavors.

 

Remulla pointed out in a four-page legal opinion that,

 

Previously, the ban on e-cigarette products applied to the products themselves, while the new law now regulates the packaging, labeling, display, or marketing of e-cigarette products. Therefore, we can harmonize the regulations of the two laws.

 

Given that there appears to be no contradiction between the two laws, and the legislative body has not clearly indicated an intention to repeal RA 11467, both laws should be appropriately applied.

 

Remulla further stated that the advertising guidelines in RA 11900 complement the prohibitions on the manufacturing, importation, sale, and distribution of products in RA 11467, collectively regulating the sale of products with flavors other than pure tobacco and mint menthol.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
PMI Global Communications Chief Moira Gilchrist: Why AI Matters More Than Ever in the Smoke-Free Transition
PMI Global Communications Chief Moira Gilchrist: Why AI Matters More Than Ever in the Smoke-Free Transition
Philip Morris International (PMI) Chief Global Communications Officer Moira Gilchrist said artificial intelligence is changing how companies understand audiences, manage owned information channels and communicate business transformation. PMI is using AI-generated audience personas to test messaging while optimizing its corporate website and other owned channels for large language models. As PMI continues its transition from cigarettes toward smoke-free products, Gilchrist said owned data and corporate channels are becoming increasingly important in demonstrating the scale of that transformation.
Aug.26
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14